This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The University of Edinburgh. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Ruth Andrew: Innovator in Glucocorticoid Metabolism
Introduction
Ruth Andrew is a prominent inventor based in Edinburgh, GB. She has made significant contributions to the field of glucocorticoid metabolism, particularly in the treatment of inflammation. Her innovative work has the potential to impact therapeutic approaches in this area.
Latest Patents
Ruth Andrew holds a patent titled "Treatment of inflammation with 5α reduced metabolites." This invention relates to the modulation of glucocorticoid metabolism. Specifically, it focuses on the modulation of the functional activity of the glucocorticoid receptor by utilizing 5α reduced metabolic breakdown products of glucocorticoids. This patent highlights her expertise and dedication to advancing medical science.
Career Highlights
Ruth Andrew is affiliated with The University of Edinburgh, where she conducts her research and development. Her work at the university has allowed her to explore innovative solutions to complex medical challenges.
Collaborations
Ruth has collaborated with notable colleagues, including Brian Robert Walker. These partnerships have fostered a collaborative environment that enhances the research output and innovation in her field.
Conclusion
Ruth Andrew is a trailblazer in the field of glucocorticoid metabolism, with her patent showcasing her innovative approach to treating inflammation. Her contributions to The University of Edinburgh and her collaborations with esteemed colleagues further solidify her impact in the scientific community.